Seems improbable that results would be shocking given:
1) First 4 months top line growth above expectation, GP margins on track, 30% operating costs were being targeted for reduction (30% wouldn't be shocking). Unless last 2 months fell off a cliff, it's hard to see how they could materially miss guidance;
2) "Insiders" have not be selling (contrary to some comments above). Directors purchased in December. I can't imagine this occurring if trading conditions had been facing such headwinds during Nov/Dec (which would have had to have been noticeable at time of purchase).
3) If halt relates to impairment charges, there's a broad range of discretion & assumptions built into these accounting adjustments, and while they are indicative of integration risk (and possible overpayment) it is best guess accounting only & does not reflect current cashflows. Can also be influenced heavily by the auditors broader materiality concerns, and requirements to be conservative.
At current prices, there's already fairly significant pessimism priced into the valuation, so would not expect an impairment charge to slash the price (don't hold me to this though!)
PGC Price at posting:
57.5¢ Sentiment: None Disclosure: Not Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)